85373-96-2

Basic information

• Product Name: 2-Bromo-4-carboxy-alpha,alpha,alpha-trifluoroanisole
• Synonyms: 2-Bromo-4-carboxy-alpha,alpha,alpha-trifluoroanisole;3-Bromo-4-(trifluoromethoxy)benzoic acid 98%;3-broMo-4-(trifluoroMethoxy)benzoic acid;3-Bromo-4-(trifluoromethoxy)benzoicacid98%
• CAS NO: 85373-96-2
• Molecular Formula: C₈H₄BrF₃O₃
• Molecular Weight: 285.0147696
• Mol File: 85373-96-2.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 279.6±40.0 °C(Predicted)
• Appearance: /
• Density: 1.797±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 3.46±0.10(Predicted)
• CAS DataBase Reference: 2-Bromo-4-carboxy-alpha,alpha,alpha-trifluoroanisole(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Bromo-4-carboxy-alpha,alpha,alpha-trifluoroanisole(85373-96-2)
• EPA Substance Registry System: 2-Bromo-4-carboxy-alpha,alpha,alpha-trifluoroanisole(85373-96-2)

Safety Data

• Hazardous Substances Data: 85373-96-2(Hazardous Substances Data)

Usage

General Description

2-Bromo-4-carboxy-alpha,alpha,alpha-trifluoroanisole is a chemical compound with the molecular formula C9H4BrF3O2. It is a derivative of alpha,alpha,alpha-trifluoroanisole, which is commonly used as a building block in organic synthesis. The presence of a bromine atom and a carboxy functional group in the compound gives it unique reactivity and properties. It can be used as a reagent in the synthesis of various organic compounds, and also as an intermediate in the production of pharmaceuticals and agrochemicals. The compound is a white to light brown powder and is typically stored and handled under controlled conditions due to its reactive nature. Overall, 2-Bromo-4-carboxy-alpha,alpha,alpha-trifluoroanisole has a wide range of applications in the field of organic chemistry and chemical synthesis.

Upstream product

• 85366-66-1 3-bromo-4-(trifluoromethoxy)benzaldehyde 
• 330-12-1 4-trifluoromethoxybenzoic acid 
• 656-06-4 3-amino-4-(trifluoromethoxy)benzoic acid 

Downstream Products

• 1174512-65-2 3-cyano-4-(trifluoromethoxy)benzoic acid 
• 1131594-45-0 methyl 3-bromo-4-(trifluoromethoxy)benzoate 

Relevant articles and documents

SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

The present invention relates to certain substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives of Formula (Ia) and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists of the S1P1 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of S1P1 receptor-associated disorders, for example, psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type I diabetes, acne, microbial infections or diseases and viral infections or diseases.

DIHYDRO- 1H- PYRROLO [1,2-A] INDOL-1-YL CARBOXYLIC DERIVATIVES WHICH ACT AS S1P1 AGONISTS

The present invention relates to certain (1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl carboxylic acid derivatives of Formula (Ia) and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists of the S1P1 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of S1P1 associated disorders, for example, psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type I diabetes, sepsis, myocardial infarction, ischemic stroke, acne, microbial infections or diseases and viral infections or diseases.